Effect of rosiglitazone on myocardial blood flow regulation in type 2 diabetes

Trial Profile

Effect of rosiglitazone on myocardial blood flow regulation in type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2009

At a glance

  • Drugs Glibenclamide; Rosiglitazone
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2009 Results published in Metabolism Clinical and Experimental.
    • 06 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top